213 related articles for article (PubMed ID: 27702824)
61. Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.
Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
[TBL] [Abstract][Full Text] [Related]
62. Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.
Pinto EM; Rodriguez-Galindo C; Pounds SB; Wang L; Clay MR; Neale G; Garfinkle EAR; Lam CG; Levy CF; Pappo AS; Zambetti GP; Ribeiro RC
J Clin Oncol; 2017 Dec; 35(35):3956-3963. PubMed ID: 29058986
[TBL] [Abstract][Full Text] [Related]
63. Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.
Wincewicz A; Kowalik A; Zięba S; Kopczyński J; Góźdź S; Sulkowski S
Pol J Pathol; 2016; 67(4):307-312. PubMed ID: 28547957
[TBL] [Abstract][Full Text] [Related]
64. Analysis of the p53 gene by PCR-SSCP in ten cases of Wilms' tumor.
Defavery R; Lemos JA; Kashima S; Bernardes JE; Scridelli CA; Covas DT; Tone LG
Sao Paulo Med J; 2000 Mar; 118(2):49-52. PubMed ID: 10772697
[TBL] [Abstract][Full Text] [Related]
65. Frequency and heritability of WT1 mutations in nonsyndromic Wilms' tumor patients: a UK Children's Cancer Study Group Study.
Little SE; Hanks SP; King-Underwood L; Jones C; Rapley EA; Rahman N; Pritchard-Jones K
J Clin Oncol; 2004 Oct; 22(20):4140-6. PubMed ID: 15483024
[TBL] [Abstract][Full Text] [Related]
66. Botryoid Wilms tumor: a non-existent "entity" causing diagnostic and staging difficulties.
Vujanić GM; Schiavo Lena M; Sebire NJ
Virchows Arch; 2019 Feb; 474(2):227-234. PubMed ID: 30515564
[TBL] [Abstract][Full Text] [Related]
67.
Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
[TBL] [Abstract][Full Text] [Related]
68. Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.
Chiang MR; Kuo CW; Wang WC; Hou TC; Kuo CY; Lu MY; Lai YC
Pathol Oncol Res; 2019 Jul; 25(3):1199-1206. PubMed ID: 30671724
[TBL] [Abstract][Full Text] [Related]
69. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
70. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
[TBL] [Abstract][Full Text] [Related]
71. Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group.
Koshinaga T; Takimoto T; Okita H; Tanaka Y; Inoue E; Oue T; Nozaki M; Tsuchiya K; Haruta M; Kaneko Y; Fukuzawa M
Pediatr Int; 2019 Apr; 61(4):351-357. PubMed ID: 30786111
[TBL] [Abstract][Full Text] [Related]
72. Immunophenotype, mRNA expression, and gene structure of p53 in Wilms' tumors.
el Bahtimi R; Hazen-Martin DJ; Re GG; Willingham MC; Garvin AJ
Mod Pathol; 1996 Mar; 9(3):238-44. PubMed ID: 8685221
[TBL] [Abstract][Full Text] [Related]
73. TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
Fountzilas G; Giannoulatou E; Alexopoulou Z; Zagouri F; Timotheadou E; Papadopoulou K; Lakis S; Bobos M; Poulios C; Sotiropoulou M; Lyberopoulou A; Gogas H; Pentheroudakis G; Pectasides D; Koutras A; Christodoulou C; Papandreou C; Samantas E; Papakostas P; Kosmidis P; Bafaloukos D; Karanikiotis C; Dimopoulos MA; Kotoula V
Oncotarget; 2016 May; 7(22):32731-53. PubMed ID: 27129168
[TBL] [Abstract][Full Text] [Related]
74. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
[TBL] [Abstract][Full Text] [Related]
75. Results of the Third AIEOP Cooperative Protocol on Wilms Tumor (TW2003) and Related Considerations.
Spreafico F; Biasoni D; Lo Vullo S; Gandola L; D'Angelo P; Terenziani M; Bianchi M; Provenzi M; Indolfi P; Pession A; Nantron M; Di Cataldo A; Morosi C; Perotti D; Catania S; Bellani FF; Collini P;
J Urol; 2017 Nov; 198(5):1138-1145. PubMed ID: 28655531
[TBL] [Abstract][Full Text] [Related]
76. Outcomes based on histopathologic response to preoperative chemotherapy in children with bilateral Wilms tumor: A prospective study (COG AREN0534).
Chintagumpala MM; Perlman EJ; Tornwall B; Chi YY; Kim Y; Hoffer FA; Kalapurakal JA; Warwick AB; Shamberger RC; Khanna G; Hamilton TE; Gow KW; Paulino AC; Gratias EJ; Mullen EA; Geller JI; Fernandez CV; Ritchey ML; Grundy PE; Dome JS; Ehrlich PF
Cancer; 2022 Jul; 128(13):2493-2503. PubMed ID: 35383900
[TBL] [Abstract][Full Text] [Related]
77. New developments in the pathology of Wilms tumor.
Beckwith JB
Cancer Invest; 1997; 15(2):153-62. PubMed ID: 9095211
[TBL] [Abstract][Full Text] [Related]
78. TRIM28 variants and Wilms' tumour predisposition.
Hol JA; Diets IJ; de Krijger RR; van den Heuvel-Eibrink MM; Jongmans MC; Kuiper RP
J Pathol; 2021 Jul; 254(4):494-504. PubMed ID: 33565090
[TBL] [Abstract][Full Text] [Related]
79. Diffuse Anaplastic Wilms Tumor in a Child With LAMA2 -related Muscular Dystrophy.
Shah R; Mohamed D; Ramos-Platt LM; Grikscheit TC; Zhou S; Wong KK; Mascarenhas L
J Pediatr Hematol Oncol; 2022 Nov; 44(8):474-478. PubMed ID: 35731920
[TBL] [Abstract][Full Text] [Related]
80. TP53 mutation analysis of malignant peripheral nerve sheath tumors.
Verdijk RM; den Bakker MA; Dubbink HJ; Hop WC; Dinjens WN; Kros JM
J Neuropathol Exp Neurol; 2010 Jan; 69(1):16-26. PubMed ID: 20010306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
